ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 93 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,395,000 | +275.4% | 83,773 | +119.8% | 0.00% | +300.0% |
| Q3 2015 | $638,000 | -73.2% | 38,121 | -58.1% | 0.00% | -75.0% |
| Q2 2015 | $2,385,000 | +332.8% | 90,942 | +188.8% | 0.00% | +300.0% |
| Q1 2015 | $551,000 | +137.5% | 31,493 | +134.4% | 0.00% | – |
| Q4 2014 | $232,000 | – | 13,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,474,482 | $38,661,000 | 18.12% |
| GREAT POINT PARTNERS LLC | 772,600 | $20,258,000 | 7.90% |
| BOW STREET LLC | 126,870 | $3,327,000 | 1.61% |
| Opaleye Management Inc. | 150,000 | $3,933,000 | 1.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 316,690 | $8,304,000 | 0.64% |
| WALL STREET ASSOCIATES | 225,000 | $5,899,000 | 0.56% |
| Granite Point Capital Management, L.P. | 61,813 | $1,621,000 | 0.47% |
| EMERALD ADVISERS, LLC | 348,721 | $9,143,000 | 0.44% |
| TFS CAPITAL LLC | 97,652 | $2,560,000 | 0.25% |
| Spark Investment Management LLC | 59,300 | $1,553,000 | 0.22% |